Venetoclax Combined With Homoharringtonine and Cytarabine in Induction for AML
Clinical trial NCT05805098 · RECRUITING
Trial details
- NCT number
- NCT05805098
- Sponsor
- The First Affiliated Hospital of Soochow University
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2025-03-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.